Unique ID issued by UMIN | UMIN000034838 |
---|---|
Receipt number | R000039190 |
Scientific Title | An evaluation of the change of plasma beta-carotene and alpha-carotene concentration after the co-ingestion of dairy products and vegetables in human subjects |
Date of disclosure of the study information | 2018/11/11 |
Last modified on | 2019/05/13 10:12:18 |
An evaluation of the change of plasma beta-carotene and alpha-carotene concentration after the co-ingestion of dairy products and vegetables in human subjects
An evaluation of the change of plasma carotenoid concentration after the co-ingestion of dairy products and vegetables
An evaluation of the change of plasma beta-carotene and alpha-carotene concentration after the co-ingestion of dairy products and vegetables in human subjects
An evaluation of the change of plasma carotenoid concentration after the co-ingestion of dairy products and vegetables
Japan |
Healthy subjects
Adult |
Others
NO
To confirm the change of plasma carotenoid concentration after the co-ingestion of dairy products and vegetables
Bio-availability
Plasma beta-carotene, alpha-caroten concentration
Plasma retinyl palmitate concentration
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Placebo
2
Prevention
Food |
Subjects receive a single dose of the active food. After the washout period (from 13 days to 20 days), subjects receive a single dose of the placebo food.
Subjects receive a single dose of the placebo food. After the washout period (from 13 days to 20 days), subjects receive a single dose of the active food.
20 | years-old | <= |
35 | years-old | >= |
Male
1) Subjects giving written informed consent
2) Males aged 20 to 35 years old when consent acquisition
3) Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2
1) Subjects who routinely use pharmaceuticals, quasi-drugs, dietary supplement, and consume food for specified health uses, supplements containing carotenoids more than two days per week
2) Subjects who have chronic diseases necessitating treatments and/or medications
3) Subjects who have abnormal lipid metabolism, glucose metabolism, liver function, or kidney function
4) Subjects who have food allergy
5) Subjects who have lactose intolerance
6) Subjects who received digestive surgical procedures
7) Subjects who are habitual smokers within a month of study enrollment
8) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month
9) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period
10) Subjects who determine ineligible by the principal investigator or sub-investigator
16
1st name | Yukio |
Middle name | |
Last name | Asami |
Meiji Co., Ltd.
Food Microbiology Research Laboratories, R&D Division
192-0919
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5822
yukio.asami@meiji.com
1st name | Masashi |
Middle name | |
Last name | Morifuji |
Meiji Co., Ltd.
Food Microbiology Research Laboratories, R&D Division
192-0919
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5822
masashi.morifuji@meiji.com
Meiji Co., Ltd.
Meiji Co., Ltd.
Profit organization
Meiji Institutional Review Board
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5900
MEIJI.IRB@meiji.com
YES
18092004
CPCC Institutional Review Board
チヨダパラメディカルケアクリニック(東京都)
2018 | Year | 11 | Month | 11 | Day |
Unpublished
16
Completed
2018 | Year | 09 | Month | 20 | Day |
2018 | Year | 09 | Month | 20 | Day |
2018 | Year | 11 | Month | 11 | Day |
2019 | Year | 03 | Month | 26 | Day |
2018 | Year | 11 | Month | 09 | Day |
2019 | Year | 05 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039190